NRAS Q61P-Mutated Therapy-Related Myelodysplastic Syndrome With Concurrent Plasma Cell Neoplasm: Unusual Presentation with Prognostic Implications

2026 ASCP/CAP-ACP Annual Meeting · 18 November 2026 · 12:00–12:45 · 517ABC - Exhibit Hall

NRAS Q61P-Mutated Therapy-Related Myelodysplastic Syndrome With Concurrent Plasma Cell Neoplasm: Unusual Presentation with Prognostic Implications was a session at 2026 ASCP/CAP-ACP Annual Meeting on 18 November 2026 in Montreal, with 1 speaker on record.

Speakers

• Marianne Yassa — Speaker University of South Alabama